WHAT WE DO
Medical Literature Monitoring (MLM-AI)
The first product in development is aimed at Medical Literature Monitoring, which is part of routine pharmacovigilance activities.
MLM-AI empowers medicinal product licence holders, sponsors, patients, healthcare professionals and scientists with accurate information about safety, efficacy and quality of medicinal products.
MLM-AI is a validated cloud-based SaaS or API tool.
MLM-AI
-
Has a seamless integrated workflow
-
Automates the detection of adverse events and special situations using AI
-
Reduce literature monitoring cost and time
-
Produce higher quality results and better insights
LEADERSHIP TEAM
biologit is an ADAPT Centre research team working with Professor Lucy Hederman within Trinity College Dublin, School of Computer Sciences & Statistics. Funded by Enterprise Ireland Commercialisation Fund.
Nicole Baker, PhD
CEO
Immunologist and Pharmacovigilance Professional with extensive knowledge in global legislation and guidelines for Medical Affairs, Regulatory Affairs, Pharmacovigilance and Clinical Trials, gained by leading and managing global, multi-disciplinary teams. Overall 20 years’ experience gained within Academia, Pharmaceutical Industry, Regulatory Authority, Clinical Research Organisation and Start-up.
Bruno Ohana, PhD
CTO
Experienced Technologist and Engineering Leader with broad industry experience spanning a career of over 20 years, having performed senior engineering/engineering management roles on large scale Cloud Infrastructure, Fintech, Healthcare and Artificial Intelligence Services.
Sean Murphy
CFO
Professional investment banking; 15 years in London. Serial entrepreneur with operational start-up experience and three successful exits. Skilled in international business development.